CanSino Biologics (6185.HK) - Will the COVID-19 Vaccine Be the Turning Point?
This article analyzed CanSino's core technology platforms, key products in the pipeline, insights on the products and core competitiveness and also...
465 Views
Beijing Wantai Biological (603392.CH) - After A 3839% Rally, Let's Look at Some Concerns
Behind the outstanding performance in stock price,there could be some concerns that deserve to pay attention to in business side, financial...
445 Views
Chongqing Zhifei Biological Products- Promising Future After Successful Renewal of Contract with MSD
This article analyzed Chongqing Zhifei Biological Products in terms of it agency business, self-developed products, forecast and rating, as well as...
659 Views
Hang Seng Index Rebalance - Big Turnover, Big Impact, Some Surprises and More Changes to Come
The Hang Seng Indexes Company Limited (HSIL) announced the results of its review of the Hang Seng Family of Indexes post market close on 14 August....
1.2k Views
SH/SZ Connect Flow Weekly: Active Flows for Vaccine Stocks
In our weekly Shanghai/Shenzhen Connect Ideas series, we aim to highlight key stocks and sectors which the mainland investors traded via the...
359 Views